Abbott Laboratories is seeking to enforce its patent rights
relating to testosterone gel product, a drug that the Company
sells under the trademark AndroGel(R).
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.